TuisFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Vorige sluiting
$9,90
Dagwisseling
$9,78 - $9,92
Jaarwisseling
$5,51 - $10,57
Markkapitalisasie
3,05 mjd USD
Gemiddelde volume
4,91 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 169,06 m | 19,46% |
Bedryfskoste | 115,32 m | 11,49% |
Netto inkomste | 17,31 m | 357,19% |
Netto winsgrens | 10,24 | 315,58% |
Wins per aandeel | 0,17 | 70,00% |
EBITDA | 36,14 m | 34,00% |
Effektiewe belastingkoers | 49,51% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 263,84 m | 5,64% |
Totale bates | 868,81 m | 10,46% |
Totale aanspreeklikheid | 638,39 m | 5,04% |
Totale ekwiteit | 230,42 m | — |
Uitstaande aandele | 308,53 m | — |
Prys om te bespreek | 13,20 | — |
Opbrengs op bates | 10,17% | — |
Opbrengs op kapitaal | 12,97% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 17,31 m | 357,19% |
Kontant van bedrywe | 35,66 m | 255,24% |
Kontant van beleggings | -1,30 m | -103,79% |
Kontant van finansiering | -1,32 m | -107,25% |
Netto kontantverandering | 31,84 m | 30,16% |
Beskikbare kontantvloei | 42,35 m | 247,11% |
Meer oor
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Gestig
04 Feb. 2002
Webwerf
Werknemers
499
